Anaplastic thyroid carcinoma: A case of a young women that reports a survival exceeding 6 years

European Review for Medical and Pharmacological Sciences

Volumn 11, Issue 1, 2007, Pages 69-71

  Batori, Mariano ^a   Chatelou, E ^a   Straniero, A ^a   Ruggieri, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anaplastic thyroid carcinoma; ATC; Survival; Thyroid cancer

Indexed keywords

DOXORUBICIN;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; BONE SCINTISCANNING; CANCER CONTROL; CANCER GROWTH; CANCER SURVIVAL; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; MULTIMODALITY CANCER THERAPY; NECK TUMOR; OUTCOME ASSESSMENT; PROGNOSIS; SURVIVAL TIME; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; WHOLE BODY CT;

ADULT; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33947692260     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Veness MJ, Porter GS, Morgan GJ. Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach. ANZ J Surg 2004; 74: 559-562.
2. Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinoma due to BRAF and p53 mutations. Cancer 2005; 103: 2261-2268.
3. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005; 12: 245-262.
4. Schmutzler C, Koehrle J. Innovative strategies for the treatment of thyroid cancer. Eur J Endocrinol 2000; 143: 15-24.
5. Khan N, Oriuchi N, Higuchi T, Endo K. Review of fluorite-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinoma. Cancer Control 2005; 12: 254-260.
6. Cannizzaro MA, De Maria A, Fazzi C, Mazzone G, Terminella A, Fiorenza G, Veroux PF. II carcinoma anaplastico della tiroide: sopravvivenza a distanza. Minerva Chir 1993; 48: 1293-1299.
7. Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991; 110: 956-963.